Vir Biotechnology, Inc
San Francisco, California, United States
Purpose
to develop a prophylactic HIV vaccine using the Human Cytomegalovirus vector platform
Division
Global Health
Date
November 2021
Region Served
GLOBAL
Committed amount
$10,034,896
Grant topic
HIV
Duration (months)
44
Grantee location
San Francisco, California, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.